Is COO stock a buy or a sell according to analysts?

Of the 28 analyst ratings on The Cooper Companies, Inc., 50% are Buy or Strong Buy, 13 are Hold, and 1 are Sell. The overall consensus rating is Buy. Analyst ratings are opinions, not investment advice.

What is the analyst price target for COO?

The average analyst price target for The Cooper Companies, Inc. is $65.11. Individual targets range from $59.00 to $75.00.

When is The Cooper Companies, Inc.'s next earnings date?

The Cooper Companies, Inc. is scheduled to report earnings on December 3, 2026. Analysts expect earnings of $1.07 per share.

Does The Cooper Companies, Inc. pay a dividend?

No, The Cooper Companies, Inc. does not currently pay a dividend.

How volatile is COO stock?

COO has a beta of 0.82, meaning it has historically been less volatile than the broader market.

What sector is The Cooper Companies, Inc. in?

The Cooper Companies, Inc. operates in the Healthcare sector, the Medical - Instruments & Supplies industry, and its stock trades on NASDAQ.

Back to Markets

Open COO on Vela

The Cooper Companies, Inc.

COO

0.00

USD

+0.00+0.00%

Overview Financials News Trades Technicals Forecast Transcripts

The Cooper Companies, Inc. at a glance

Open COO on Vela

The Cooper Companies, Inc. (COO) is a Healthcare company in the Medical - Instruments & Supplies industry, headquartered in San Ramon, CA, with about 15,000 employees. Its shares trade on NASDAQ, and its IPO date is January 21, 1983. With a market capitalization of $11.6 billion, COO is a large-cap stock.

It trades an average of 3.2 million shares a day.

In its latest reported quarter (results released September 9, 2026), The Cooper Companies, Inc. posted revenue of $1.1 billion and earnings of $1.15 per share, against estimates of $1.1 billion and $1.12.

Figures as of October 25, 2026, from market data providers. Descriptive only, not financial advice.

COO: Frequently asked questions

As of October 25, 2026, The Cooper Companies, Inc. has a market capitalization of $11.6 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.